PortfoliosLab logo

BioPlus Acquisition Corp. Unit (BIOSU)

Equity · Currency in USD · Last updated Mar 26, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in BioPlus Acquisition Corp. Unit in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $10,460 for a total return of roughly 4.60%. All prices are adjusted for splits and dividends.

BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIOSU

BioPlus Acquisition Corp. Unit


BioPlus Acquisition Corp. Unit had a return of 2.55% year-to-date (YTD) and 4.81% in the last 12 months. Over the past 10 years, BioPlus Acquisition Corp. Unit had an annualized return of 3.52%, while the S&P 500 had an annualized return of -10.34%, indicating that BioPlus Acquisition Corp. Unit did not perform as well as the benchmark.

1 month0.58%-0.66%
6 months4.70%5.67%
1 year4.81%-10.89%
5 years (annualized)3.52%-10.34%
10 years (annualized)3.52%-10.34%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current BioPlus Acquisition Corp. Unit Sharpe ratio is 1.84. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.

-1.00-0.500.000.501.001.502.00Dec 11Dec 18Dec 252023Jan 08Jan 15Jan 22Jan 29Feb 05Feb 12Feb 19Feb 26Mar 05Mar 12Mar 19
BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Dividend History

BioPlus Acquisition Corp. Unit doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the BioPlus Acquisition Corp. Unit. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the BioPlus Acquisition Corp. Unit is 1.39%, recorded on Feb 24, 2022. It took 147 trading sessions for the portfolio to recover.



To Bottom


To Recover



-1.39%Dec 14, 202150Feb 24, 2022147Sep 26, 2022197
-0.4%Sep 27, 20221Sep 27, 202216Oct 19, 202217
-0.29%Jan 18, 20231Jan 18, 20238Jan 30, 20239
-0.29%Feb 15, 20231Feb 15, 20239Mar 1, 202310
-0.2%Dec 10, 20211Dec 10, 20211Dec 13, 20212
-0.19%Jan 11, 20231Jan 11, 20231Jan 12, 20232
-0.19%Feb 3, 20231Feb 3, 20231Feb 6, 20232
-0.1%Dec 7, 20211Dec 7, 20211Dec 8, 20212
-0.1%Nov 16, 20221Nov 16, 20227Nov 28, 20228
-0.1%Dec 8, 20221Dec 8, 20221Dec 9, 20222

Volatility Chart

Current BioPlus Acquisition Corp. Unit volatility is 1.01%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BIOSU (BioPlus Acquisition Corp. Unit)
Benchmark (^GSPC)